Treatment of fungal infections in haematology and oncology. Guidelines of the working party on infections in haematology and oncology (AGIHO) of the german society for haematology and oncology (DGHO);Therapie von pilzinfektionen in der hämatologie und onkologie leitlinien der arbeitsgemeinschaft infektionen in der hämatologie und onkologie (AGIHO) der deutschen gesellschaft für hämatologie und onkologie (DGHO)

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 50, 2001, Pages 1440-1447

  Bohme A ^a   Ruhnke, M ^b   Karthaus, M ^c   Einsele, H ^d   Guth, S ^e   Heussel G ^e   Heulssel C P ^e   Junghanss, C ^f   Kern, W V ^g   Kubin, T ^h   Sezer, O ^b   Silling, G ⁱ   Sudhoff T ^j   Szelenyi H ^k   Ullmann, A J ^e  

^a GOETHE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c EVANGELISCHES KRANKENHAUS   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f Univklinikum Rostock   (Germany)

^g UNIVERSITY OF ULM MEDICAL SCHOOL   (Germany)

^h STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

^j UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^k CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; ASTEMIZOLE; CALCIUM ANTAGONIST; CARBAMAZEPINE; CASPOFUNGIN; CISAPRIDE; CYCLOSPORIN A; CYTOSTATIC AGENT; DIGITALIS; DIPHENHYDRAMINE; FLUCONAZOLE; FLUCYTOSINE; HYDROCORTISONE; ITRACONAZOLE; MICAFUNGIN; NYSTATIN; PARACETAMOL; PETHIDINE; PHENYTOIN; POSACONAZOLE; PYRROLE DERIVATIVE; QUINIDINE; RIFAMPICIN; UNINDEXED DRUG; VORICONAZOLE;

ARTIFICIAL EMBOLISM; ASPERGILLUS; BLOOD DISEASE; CANCER; CANDIDA; CELL TRANSPLANTATION; CLINICAL TRIAL; CONFERENCE PAPER; CRYPTOCOCCUS NEOFORMANS; DISEASE CLASSIFICATION; DRUG ADMINISTRATION ROUTE; DRUG FORMULATION; DRUG MECHANISM; GERMANY; GRANULOCYTE; HEALTH CARE ORGANIZATION; HUMAN; LUNG ASPERGILLOSIS; MUCORMYCOSIS; MYCOSIS; PRACTICE GUIDELINE; SIDE EFFECT; TREATMENT OUTCOME;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDIASIS; GERMANY; HEMATOLOGIC DISEASES; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES; NEOPLASMS; SOCIETIES, MEDICAL;

EID: 0035861865     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-18975     Document Type: Conference Paper

References (49)

1. Congestive heart failure associated with itraconazole
2. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior AmB therapy
3. Surgical management of invasive pulmonary aspergillosis in neutropenic patients
4. Diagnostik systemischer pilzinfektionen in der hämatologie. Standardempfehlungen der arbeitsgemeinschaft infektiologie in der hämatologie und onkologie der deutschen gesellschaft für Hämatologie und onkologie
5. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
6. Invasive pulmonary aspergillosis in neutropenic patients. Analysis of a series of 36 cases: Contribution of thoracic scanners and itraconazole
7. Invasive aspergillosis
8. An EORTC international multicenter randomized trial (EORTC number 19923) comparing two dosages of liposomal AmB for treatment of invasive aspergillosis
9. International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections
10. Comparison of effects of AmB deoxycholate infused over 4 or 24 hours: Randomized controlled trial
11. Venenkatheter-assoziierte infektionen bei patienten in neutropenie
12. Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole
13. Surgical aspects of resection for suspected invasive pulmonary fungal infection in neutropenic patients
14. Aneurysms complicating inflammatory diseases in immunocompromised hosts: Value of contrast-enhanced CT
15. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases
16. Early detection of chronic disseminated Candida infection in leukemia patients with febrile neutropenia: Value of computer-assisted serial ultrasound documentation
17. Effect of salt supplementation on AmB nephrotoxicity
18. Liposomal AmB compared with AmB deoxycholate in the treatment of documented and suspected neutropenia-induced invasive fungal infections
19. Liposomal AmB (AmBisome) compared with AmB both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis
20. Antimikrobielle therapie von ungeklärtem fieber bei neutropenie. Standardempfehlungen der Arbeitsgemeinschaft Infektiologie in der Hämatologie und und Onkologie der Deutschen Gesellschaff für Hämatologie und Onkologie
21. Diagnostik und Therapie von Lungeninfiltraten bei febrilen neutropenischen Patienten. Standardempfehlungen der Arbeitsgemeinschaft Infektiologie in der Hämatologie und und Onkologie der Deutschen gesellschaft für Hamatologie und Onkologie
22. Intracavitary aspergilloma: Transthoracic percutaneous injection of amphotericin gelatin solution
23. The spectrum of Fusarium infection in immunocompromised patients with haematological malignancies and in non-immunocompromised patients: A single institution experience over 10 years
24. The exciting future of antifungal therapy
25. Hematopoietic growth factors in cancer patients with invasive fungal infections
26. Randomized, double-blind trial of 1- versus 4-hour AmB infusion durations
27. 2000 Update of recommendations for the use of hematopoietic colony-stimulating factors: Evidence-based, clinical practice guidelines
28. Mucormycosis in patients with haematological malignancies: A retrospective clinical study of 37 cases
29. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes
30. Leukocyte transfusions from rhG-CSF or prednisolone stimulated donors for treatment of severe infections in immunocompromised neutropenic patients
31. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS
32. Phase I/II trial of neutrophil transfusions from donors stimulated with G-CSF and dexamethasone for treatment of patients with infections in hematopoietic stem cell transplantation
33. A randomized trial comparing fluconazole with AmB for the treatment of candidemia in patients without neutropenia
34. Practice guidelines for the treatment of candidiasis
35. Practice guidelines for the management of cryptococcal disease
36. Surgical therapy for pulmonary aspergillosis in immunocompromised patients
37. Fungal sinusitis
38. Practice guidelines for the treatment of fungal infections
39. Fungal infections of the urinary tract
40. Practice guidelines for diseases caused by aspergillus
41. Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group Criteria
42. Pulmonary mucormycosis: Results of medical and surgical therapy
43. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome
44. AmB versus AmB plus flucytosine: Poor results in the treatment of proven systemic mysoses in neutropenic patients
45. Primary cutaneous aspergillosis - An emerging infection among immunocompromised patients
46. Liposomal AmB for empirical therapy in patients with persistent fever and neutropenia
47. AmB lipid complex for invasive fungal infections
48. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis
49. Epidemiologie und interventionelle therapiestrategien infektiöser komplikationen nach allogener stammzelltransplantation